We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock
ISEE

Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

128 hedge funds and large institutions have $536M invested in IVERIC bio, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 39 increasing their positions, 39 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more call options, than puts

Call options by funds: $2.26M | Put options by funds: $737K

108% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 12

11% more funds holding

Funds holding: 115 → 128 (+13)

8% more capital invested

Capital invested by funds: $495M → $536M (+$40.8M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 39

Holders
128
Holders Change
+13
Holders Change %
+11.3%
% of All Funds
2.23%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
25
Increased
39
Reduced
39
Closed
12
Calls
$2.26M
Puts
$737K
Net Calls
+$1.52M
Net Calls Change
-$1.61M

Top Buyers

1
YCM
Yiheng Capital Management
California
+$14.7M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$11.5M
3
APM
Avidity Partners Management
Texas
+$9.03M
4
LGM
Logos Global Management
California
+$8.39M
5
CS
Candriam SCA
Luxembourg
+$4.36M

Top Sellers

1
ACA
Avoro Capital Advisors
New York
-$5.32M
2
SCM
Soleus Capital Management
Connecticut
-$3.69M
3
Citadel Advisors
Citadel Advisors
Florida
-$3.23M
4
State Street
State Street
Massachusetts
-$3.16M
5
N
Nuveen
North Carolina
-$2.79M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$42.6M -$2M -310,672 -4%
RI
2
RTW Investments
New York
$42.4M – – –
ACA
3
Avoro Capital Advisors
New York
$40.5M -$5.32M -825,000 -11%
VC
4
Vivo Capital
California
$37.6M – – –
DM
5
Deerfield Management
New York
$36.4M – – –
YCM
6
Yiheng Capital Management
California
$31.9M +$14.7M +2,271,402 +82%
PA
7
Perceptive Advisors
New York
$28.9M – – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$26.5M -$178K -27,565 -0.7%
State Street
9
State Street
Massachusetts
$20.2M -$3.16M -489,357 -13%
SCM
10
Soleus Capital Management
Connecticut
$17.7M -$3.69M -572,636 -17%
FM
11
Frazier Management
Washington
$16.1M – – –
LGM
12
Logos Global Management
California
$15.8M +$8.39M +1,300,000 +108%
SB
13
Samsara BioCapital
California
$13.4M -$1.59M -247,105 -10%
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
$13M -$713K -110,452 -5%
Assenagon Asset Management
15
Assenagon Asset Management
Luxembourg
$11.3M +$11.5M +1,784,361 New
CC
16
Commodore Capital
New York
$11M +$124K +19,200 +1%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$9.13M +$723K +112,086 +8%
BBA
18
Baker Bros. Advisors
New York
$8.87M – – –
APM
19
Avidity Partners Management
Texas
$8.83M +$9.03M +1,400,010 New
ACP
20
Acuta Capital Partners
California
$7.89M -$2.12M -329,093 -21%
Millennium Management
21
Millennium Management
New York
$7.27M +$2.1M +325,936 +39%
Ameriprise
22
Ameriprise
Minnesota
$6.9M +$151K +23,445 +2%
ACM
23
Altium Capital Management
New York
$5.7M – – –
Northern Trust
24
Northern Trust
Illinois
$5.45M +$304K +47,200 +6%
GTC
25
Ghost Tree Capital
New York
$4.58M -$2.58M -400,000 -36%
1
2 3 4 5

ISEE Hedge Fund Activity: Q2 2021 in Review

128 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q2 2021, worth a combined $536M — up 8.2% from $495M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ISEE positions and 12 closed out — a net gain of 13 holders — while 39 added to existing stakes and 39 trimmed.

The largest buyer was Yiheng Capital Management, adding an estimated $14.7M. The largest seller was Avoro Capital Advisors, cutting an estimated $5.32M.

  • 128 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q2 2021, up from 115 in Q1 2021.
  • Funds reported $536M of IVERIC bio, Inc. Common Stock stock for Q2 2021, up 8.2% quarter-over-quarter.
  • 25 funds opened new IVERIC bio, Inc. Common Stock positions in Q2 2021 and 12 closed out, a net change of +13 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q2 2021 was Yiheng Capital Management, an estimated $14.7M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q2 2021 was Avoro Capital Advisors, an estimated $5.32M sold.

Based on aggregated 13F filings for Q2 2021.